Clustering data with hclust algorithm for (Study ST002121)

Reversed phase NEGATIVE ION MODE (Analysis AN003473)
MetaboliteStructureF1F2
GlucoseME5163150.971.03
2-hydroxy-2-phenylpropanoic acidME5163160.981.02
p-Hydroxyphenylpropionic acidME5163171.040.96
Methylmalonic acidME5162910.951.05
UridineME5162930.991.01
Azelaic acidME5162981.110.89
Malic acidME5163110.941.06
Taurochenodeoxycholic acidME5162890.731.27
Cis-Aconitic acidME5163070.991.01
N-Acetyl-L-tryptophanME5163000.741.26
Maleic acidME5162990.801.20
L-LactateME5162940.991.01
FumarateME5163100.771.23
Oxalic acidME5162950.991.01
Taurocholic acidME5162860.581.42
Sebacic acidME5163010.971.03
Succinic acidME5163130.951.05
4-Hydroxybenzoic acidME5162970.981.02
2^-DeoxyinosineME5163060.991.01
N-Acetylglutamic acidME5163020.801.20
AllantoinME5163031.180.82
Phenyllactic acidME5163201.150.85
Gluconic acidME5163140.861.14
Isocitric acidME5162880.961.04
Glutaric acidME5163220.891.11
Indoxyl sulfateME5163050.591.41
CinnamoylglycineME5162870.991.01
Citramalic acidME5163211.010.99
D-FructoseME5163120.981.02
D-Glucose 6-phosphateME5163080.881.12
Docosahexaenoic acidME5163191.020.98
dUMPME5163040.731.27
Flavin adenine dinucleotideME5163090.951.05
Citraconic acidME5162901.030.97
CitrateME5162850.921.08
Malonic acidME5162960.991.01
3-Hydroxybenzoic acidME5162921.001.00
3-Hydroxyphenylpropionic acidME5163180.981.02

Factors:

F1Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 0.2ml normal saline
F2Treatment:2 times per week with 3 weeks consecutive respectively intraperitoneal injection with 25mg/kg gemcitabine in 0.2ml
Data matrix
  logo